Coverage initiated with "Buy" rating and €2.30 price target for Jefferies and €2.60 price target for Kempen Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 ALSEN) a pioneering clinical-stage
Share:
Sonova invests at €1.70 per share, to hold circa 3.7% stake in Sensorion
Companies signed a letter of intent relating to a collaboration to develop new solutions for hearing loss
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that Sonova Holding AG (headquartered in Switzerland), a leading provider of hearing solutions, will acquire a 3.7% ownership stake in Sensorion by way of subscription to a reserved share capital increase for total gross proceeds of €5 million.
Sensorion and Sonova plan a strategic collaboration in the field of innovative diagnostic and therapeutic solutions for certain types of hearing loss. To this effect, Sonova and Sensorion signed a letter of intent dated December 14, 2020 providing for an exclusive period of negotiation of a co-develop